At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,452 enrolled
Drug / intervention
Telmisartan 80mg +2 moredrug
Likely dose
Telmisartan 80mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Post Marketing Surveillance on Long Drug Use of Micombi Combination Tablets in Patients With Hypertension
In Brief
An observational study evaluating Telmisartan 80mg, Telmisartan 40mg, and 1 other intervention for Hypertension. Completed, enrolled 1,452 participants across 314 sites.
Detailed Summary
The survey is conducted to collect safety and effectiveness information in Hypertensive patients treated with Micombi Tablets on the long term use in daily clinical settings in Japan.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHypertension
CountriesJapan
CollaboratorsAstellas Pharma Inc
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJan 2010
First PostedJan 2010
Primary CompletionDec 2011
TodayJul 2026
First PostedJan 15, 2010
Enrollment StartJan 1, 2010
Primary CompletionDec 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 16.5 years ago
Interventions
Telmisartan 80mgdrug
Combination tablet
Telmisartan 40mgdrug
Combination tablet
Hydrochlorothiazide 12.5mgdrug
Combination tablet